Funded Startups in Renens
In Renens, the largest disclosed round in the 14 most recent entries is SWISSto12’s $28M (2023-09-13), which dwarfs the next-largest disclosed amounts in t…
In Renens, the largest disclosed round in the 14 most recent entries is SWISSto12’s $28M (2023-09-13), which dwarfs the next-largest disclosed amounts in this slice such as Astrocast’s $18M (2023-04-03) and Odne’s $6M (2024-03-13); most other disclosed rounds sit far below $10M (e.g., Hydromea $1M on 2026-06-22 and ClearSpace $3M on 2024-09-13). A second pattern is time concentration: 7 of the 14 rounds land in 2024 alone (2024-03-13 through 2024-11-27), following earlier activity in 2023 (four entries spanning 2023-04-03 to 2023-09-13).
Sector and disclosure are mixed. Biotechnology appears in 5 entries (Testmate Health, Aspivix, SEED Biosciences, Flowbone, SwissDeCode), while 9 of 14 rows show “Series Unknown” or a blank/unnormalized series label (including Odne with a blank series and KimboCare with a blank series). Two amounts are “undisclosed” (Testmate Health on 2025-12-04 and SEED Biosciences on 2023-05-10), and the range of dates runs from 2020-10-01 (KimboCare) through the most recent 2026-06-22 (Hydromea).
Most recent rounds
14 shownRelated listings
Frequently asked
What stands out as the largest disclosed round in Renens, and how does it compare to the rest of the disclosed amounts shown?
SWISSto12’s $28M on 2023-09-13 is the largest disclosed amount in the 14-row view and is significantly larger than the next-largest disclosed rounds: Astrocast’s $18M (2023-04-03) and Odne’s $6M (2024-03-13). Most other disclosed entries are clustered well below $10M (e.g., Hydromea $1M on 2026-06-22; EM Path Tech $130K on 2026-06-08).
Are there clusters in timing among these Renens rounds?
Yes. Seven of the 14 rounds are dated in 2024 (from 2024-03-13 with Odne through 2024-11-27 with KITRO). Another concentration appears in 2023, where four entries fall between 2023-04-03 (Astrocast) and 2023-09-13 (SWISSto12).
Which entries were most recent in this slice (last 90 days of the shown window), and what amounts do they include?
The most recent dates shown are in June 2026: Hydromea closed on 2026-06-22 for $1M and EM Path Tech closed on 2026-06-08 for $130K, with no additional 2026 entries beyond those two in the table. Earlier, the next-most-recent disclosed round is PAVE Space at $130K on 2025-06-26 (2025-12-04 for Testmate Health is undisclosed).
How concentrated are sectors, and does biotechnology dominate?
Biotechnology is the clear concentration with 5 of the 14 entries: Testmate Health (undisclosed, 2025-12-04), Aspivix ($560K, 2024-06-27), SEED Biosciences (undisclosed, 2023-05-10), Flowbone ($2M, 2022-10-05), and SwissDeCode ($4M, 2021-01-25). The remaining entries are spread across hardware (multiple), consumer electronics (multiple), and other single-category labels (e.g., Apps for KimboCare on 2020-10-01).
Are disclosure and stage labels consistent, or do outliers/unknowns complicate comparisons?
Stage classification is frequently missing or informal: 9 of 14 rows are “Series Unknown,” blank, or an unnormalized series label (including Odne and KimboCare with blank series fields). Two entries list “undisclosed” amounts (Testmate Health on 2025-12-04 and SEED Biosciences on 2023-05-10), while stage appears explicitly only for Flowbone (“Seed,” $2M on 2022-10-05) and Astrocast’s row has “Series Unknown” despite its $18M amount (2023-04-03).
Is there a notably small disclosed round that behaves like an outlier versus the rest of the disclosed amounts?
Among disclosed amounts, EM Path Tech’s $130K on 2026-06-08 is the smallest figure shown. Several other low disclosed rounds are higher than that floor (e.g., PAVE Space $130K on 2025-06-26 matches it; KITRO and SEED Biosciences are undisclosed rather than lower disclosed amounts), while the upper end is anchored by SWISSto12’s $28M on 2023-09-13.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.